Director's Report to the National Advisory Council on Drug Abuse
February, 2002
Extramural Policy and Review Activities
Reviews
For this Council cycle, the Office of Extramural Affairs arranged and managed fifteen review meetings for applications in its standing committees, applications in conflict- of-interest with standing committees, and submissions to special initiatives. One contract proposal review meeting was held and sixteen concept reviews were completed.
The reviews for NIDA’s chartered committees were held. These consist of NIDA-E (Treatment Review Committee), NIDA-F (Health Services Review Committee), NIDA-L (Medications Development Committee), and NIDA-K (Training Committee). Three Special Emphasis Panels were held to review applications in conflict with the chartered committees. Six Special Emphasis panels were constituted for reviews of specific mechanisms: centers, program projects, conferences, and Minority Institutions Drug Abuse Research Development Program applications. In addition, OEA staff managed the reviews for B/START and Cutting Edge Basic Research Award (CEBRA) mechanisms.
The Contracts Review Branch managed the following reviews of proposals:
| Proposal Review |
| NO1DA-2-1108 |
Research Dissemination to the Entertainment Industry |
| SBIR Concept Reviews |
| N43DA-2-7727 |
Analytical Techniques Program |
| N43DA-2-5518 |
Prevention Training |
| N43DA-2-1109 |
Development of Science Education Materials |
| N43DA-2-8819 |
Medicinal Chemistry-Design Synthesis of Treatment Agents for Drug Abuse |
| N43DA-2-8820 |
Dosage Form Development |
| N43DA-2-5517 |
Developing New Technologies for Drug Abuse Prevention Delivery: Translation of Empirically Validated Prevention Strategies and Programs into New Technology |
| N43DA-2-7731 |
Novel Drug Delivery System for the Mouse |
| N43DA-2-7726 |
Functional Imaging Agent |
| N43DA-2-7714 |
Technologies for Localizing Gene Expression |
| N43DA-2-7715 |
Activity-based Protein Profiling |
| N43DA-2-7730 |
High-Throughput Screening of Functional Activity of Proteins Using Bio-sensor-based Technology |
| N43DA-2-5506 |
Developing Methodologies for Cost Analysis of Substance Abuse Prevention Programs |
| N43DA-2-5506 |
Developing Prevention Services Analytic Tools for Improved Substance Abuse Prevention Delivery |
| N43DA-2-5513 |
Develop and Maintain Substance Abuse Prevention Methodological Software |
| N43DA-2-7709 |
Virtual Reality for Treatment of Pain |
| N43DA-2-7710 |
Virtual Reality for Treatment of Drug Abuse |
Staff Training and Policy Development
The OEA Symposium Series continued its monthly meetings for staff development, under the direction of Dr. Mark Swieter, SRA, Basic Sciences Review Branch. A variety of case studies and updates on NIH extramural policies were presented and discussed.
Dr. Teresa Levitin, Director, OEA, has represented NIDA on an NIH-wide committee to address continuing education requirements.
Mr. Eric Zatman, Contracts Review Branch, is representing NIDA on a trans-NIH committee that is examining and updating the NIH policies and procedures for review of contracts, as contained in the NIH Manual section entitled, “Initiation, Review, Evaluation, and Award of Research & Development (R&D) Contract Projects.”
[Office of the Director][Report Index][Next Report Section]
|
